Quince Therapeutics Statistics

Total Valuation

QNCX has a market cap or net worth of $92.39 million. The enterprise value is $75.17 million.

Market Cap	92.39M
Enterprise Value	75.17M

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

QNCX has 53.71 million shares outstanding. The number of shares has increased by 8.75% in one year.

Current Share Class	53.71M
Shares Outstanding	53.71M
Shares Change (YoY)	+8.75%
Shares Change (QoQ)	+6.25%
Owned by Insiders (%)	11.05%
Owned by Institutions (%)	13.92%
Float	44.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.86
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 1.49.

Current Ratio	5.00
Quick Ratio	4.78
Debt / Equity	1.49
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.71

Financial Efficiency

Return on equity (ROE) is -167.04% and return on invested capital (ROIC) is -53.80%.

Return on Equity (ROE)	-167.04%
Return on Assets (ROA)	-19.33%
Return on Invested Capital (ROIC)	-53.80%
Return on Capital Employed (ROCE)	-35.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, QNCX has paid $134,000 in taxes.

Income Tax	134,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +149.28% in the last 52 weeks. The beta is 1.02, so QNCX's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	+149.28%
50-Day Moving Average	1.57
200-Day Moving Average	1.49
Relative Strength Index (RSI)	52.60
Average Volume (20 Days)	217,956

Short Selling Information

The latest short interest is 886,689, so 1.65% of the outstanding shares have been sold short.

Short Interest	886,689
Short Previous Month	740,893
Short % of Shares Out	1.65%
Short % of Float	1.98%
Short Ratio (days to cover)	3.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.98M
Pretax Income	-30.20M
Net Income	-49.03M
EBITDA	-38.82M
EBIT	-38.98M
Earnings Per Share (EPS)	-$1.10

Full Income Statement

Balance Sheet

The company has $34.71 million in cash and $17.49 million in debt, giving a net cash position of $17.22 million or $0.32 per share.

Cash & Cash Equivalents	34.71M
Total Debt	17.49M
Net Cash	17.22M
Net Cash Per Share	$0.32
Equity (Book Value)	11.74M
Book Value Per Share	0.22
Working Capital	29.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.83 million and capital expenditures -$453,000, giving a free cash flow of -$36.28 million.

Operating Cash Flow	-35.83M
Capital Expenditures	-453,000
Free Cash Flow	-36.28M
FCF Per Share	-$0.68

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNCX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.75%
Shareholder Yield	-8.75%
Earnings Yield	-53.07%
FCF Yield	-39.27%

Analyst Forecast

The average price target for QNCX is $8.00, which is 365.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	365.12%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1